Trials / Terminated
TerminatedNCT04072393
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
A Pilot Trial of Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Other than optimizing medical management of cardiac risk factors, and reducing radiotherapy (RT) dose to the heart, there currently exist no interventions to mitigate or reverse the adverse cardiac effects of RT. Aerobic exercise has been demonstrated to improve patient quality of life, cardiac outcomes, and cardiorespiratory fitness in patients with cancer receiving cardiotoxic systemic therapies, but the effects of aerobic exercise on patients at high risk for radiation induced heart disease (RIHD) is unknown. In addition, home-based cardiac rehabilitation has not been tested in patients with thoracic cancers.
Conditions
- Lung Cancer
- Esophageal Cancer
- Thoracic Cancer
- Hodgkin Lymphoma
- Hodgkin Disease
- Non-hodgkin Lymphoma
- Sarcoma
- Thymoma
- Breast Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Home-based cardiac rehabilitation | -Patients will be evaluated by the clinical team at The Heart Care Institute (HCI). They will receive a heart rate monitor, blood pressure monitor, and weight scale that they will take home with them. They will receive training on how to use the heart rate monitor and blood pressure monitor. They will receive training on how to record their exercises and weights in the teleHeart application by an exercise physiologist from HCI. Within 6 weeks of completion of standard of care radiation therapy or cytotoxic chemotherapy (whichever is last), they will be prescribed a course of home-based CR by a cardiologist at HCI and be instructed on the regimen by an exercise physiologist from HCI. |
Timeline
- Start date
- 2021-01-15
- Primary completion
- 2024-05-15
- Completion
- 2024-05-15
- First posted
- 2019-08-28
- Last updated
- 2024-07-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04072393. Inclusion in this directory is not an endorsement.